List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #931 to #980.
- ARBs → Angiotensin II receptor antagonist
- ARCH → Amiodarone Reduction In Coronary Heart Trial
- ARCHeR → For Revascularization Of Carotids In High-Risk Patients
- ARDS → Acute respiratory distress syndrome
- AREDS → Age-Related Eye Disease Study
- ARF → Acute kidney injury
- ARG-911 → Argatroban-911
- ARG-915 → Argatroban-915
- ARGAMI-2 → Argatroban For Acute Myocardial Infarction
- ARIC → Atherosclerosis Risk In Communities
- ARIES 1 and 2 → Ambrisentan In Pulmonary Arterial Hypertension Efficacy Study 1 And 2
- ARISE → Aggressive Reduction Of Inflammation Stops Events
- ARI Sodium Iodide (I123) 1-12 MBq → Sodium iodide
- ARI Sodium Iodide (I123) 100-750 MBq → Sodium iodide
- ARMS → Apsac Reocclusion Multicenter Study
- ARMYDA → Atorvastatin For Reduction Of Myocardial Damage During Angioplasty
- ARMYDA-2 → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 2
- ARMYDA-3 → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 3
- ARMYDA-4 → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 4
- ARMYDA-5 → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 5
- ARMYDA-ACS → Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Acute Coronary Syndromes
- ARMYDA-RECAPTURE → Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Recapture
- ARMYDA-RELOAD → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty-Reload
- ARNT gene → Aryl hydrocarbon receptor nuclear translocator
- ARPEGGIO → Rimonabant Improves Glycemic Control In Insulin-Treated Type 2 Diabetes
- ARPKD → Polycystic kidney disease
- ARR → Absolute risk reduction
- ART → AIDS antiretroviral drugs
- ARTIST → Angioplasty Versus Rotational Atherectomy For Treatment Of Diffuse In-Stent Restenosis Trial
- ARTISTIC → Angiorad Radiation Therapy For In-Stent Restenosis Intracoronary
- ARTS → Arterial Revascularization Therapies Study
- ARTS-II → Arterial Revascularization Therapies Study Part II: Sirolimus-Eluting Stents For The Treatment Of Patients With Multivessel De Novo Coronary Artery Lesions
- ARTS I - Five year follow-up → Five Year Clinical Follow-Up Of The Arterial Revascularisation Therapy Study
- ARVC → Arrhythmogenic right ventricular dysplasia
- ARVD → Arrhythmogenic right ventricular dysplasia
- ARVD/C → Arrhythmogenic right ventricular dysplasia
- AR Deficiency → Androgen insensitivity syndrome
- AR deficiency → Androgen insensitivity syndrome
- ASA → Aspirin
- ASAP → Effect Of Aggressive Versus Conventional Lipid Lowering On Atherosclerosis Progression In Familial Hypercholesterolemia
- ASA physical status class → Conscious sedation#ASA Physical Status Classification
- ASA physical status classification → Conscious sedation#ASA Physical Status Classification
- ASCENT → Acs Stent Clinical Equivalence In De Novo Lesions Trial
- ASCOT → Anglo-Scandinavian Cardiac Outcome Trial
- ASCOT-LLA Trial → ASCOT-LLA
- ASCOT - Blood Pressure Arm → Anglo-Scandinavian Cardiac Outcomes Trial: Blood Pressure-Lowering Arm
- ASCOT - Lipid Arm → ASCOT-LLA
- ASCVD → CAD
- ASD → Atrial septal defect
- ASFAST → Atherosclerosis And Folic Acid Supplementation Trial